Evidence map›Paper›PMID 33869117›Full record

ReviewFrontiers in pediatrics2021

Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?

Göran Läckgren, Christopher S Cooper, Tryggve Neveus, Andrew J Kirsch

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 77 citations in OpenAlex.

  1. Urinary tract infections in children.Nature reviews. Urology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dextranomer/hyaluronic acid injections for patients with vesicoureteral reflux Does the age at injection predict the outcome?Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  7. Article
  8. Neurogenic Bladder in Children with Myelomeningocele.Diseases (Basel, Switzerland) · 2025
    Review
  9. Ultrasound andMedical journal of the Islamic Republic of Iran · 2025
    Article
  10. Article
  11. Primary vesicoureteral reflux.Nature reviews. Disease primers · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Göran LäckgrenSection of Urology, Department of Pediatric Surgery, University Children's Hospital, Uppsala, Sweden.
Christopher S CooperDepartment of Urology, University of Iowa, Iowa City, IA, United States.
Tryggve NeveusDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Andrew J KirschPediatric Urology, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA, United States.
Emory University · USUniversity of Iowa · USUppsala University · SEUppsala University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vesicoureteral reflux (VUR) is associated with increased risks of urinary tract infection, renal scarring and reflux nephropathy. We review advancements over the last two decades in our understanding and management of VUR. Over time, the condition may resolve spontaneously but it can persist for many years and bladder/bowel dysfunction is often involved. Some factors that increase the likelihood of persistence (e.g., high grade) also increase the risk of renal scarring. Voiding cystourethrography (VCUG) is generally considered the definitive method for diagnosing VUR, and helpful in determining the need for treatment. However, this procedure causes distress and radiation exposure. Therefore, strategies to reduce clinicians' reliance upon VCUG (e.g., after a VUR treatment procedure) have been developed. There are several options for managing patients with VUR. Observation is suitable only for patients at low risk of renal injury. Antibiotic prophylaxis can reduce the incidence of UTIs, but drawbacks such as antibiotic resistance and incomplete adherence mean that this option is not viable for long-term use. Long-term studies of endoscopic injection have helped us understand factors influencing use and the effectiveness of this procedure. Ureteral reimplantation is still performed commonly, and robot-assisted laparoscopic methods are gaining popularity. Over the last 20 years, there has been a shift toward more conservative management of VUR with an individualized, risk-based approach. For continued treatment improvement, better identification of children at risk of renal scarring, robust evidence regarding the available interventions, and an improved VUR grading system are needed.

Indexed as

antibioticbladder/bowel dysfunctionendoscopic injectionNASHA/Dxureteral reimplantationurinary tract infectionvesicoureteral refluxvoiding cystourethrogram

Identifiers

PMID33869117
PMCPMC8044769
OpenAlexW3152420266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.